Safety and Efficacy of Intratumoral Injections of Chimeric Antigen Receptor (CAR) T Cells in Metastatic Breast Cancer
2017 · Cancer Immunology Research · 435 citations
https://doi.org/10.1158/2326-6066.cir-17-0189
J
Julia Tchou
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
280
Papers
8.9K
Citations
46
h-index
94
i10-index
Julia Tchou is an academic researcher from University of Pennsylvania. The author has contributed to research in topics: Breast Cancer Treatment Studies & CAR-T cell therapy research & Breast Implant and Reconstruction. The author has an h-index of 46, co-authored 238 publications.
ORCID: 0000-0002-2032-1579Papers by this author
worksComparison of triple‐negative and estrogen receptor‐positive/progesterone receptor‐positive/HER2‐negative breast carcinoma using quantitative fluorine‐18 fluorodeoxyglucose/positron emission tomography imaging parameters
2007 · Cancer · 246 citations
https://doi.org/10.1002/cncr.23226
Mesothelin, a novel immunotherapy target for triple negative breast cancer
2012 · Breast Cancer Research and Treatment · 178 citations
https://doi.org/10.1007/s10549-012-2018-4
Phase I Trial of Autologous RNA-electroporated cMET-directed CAR T Cells Administered Intravenously in Patients with Melanoma and Breast Carcinoma
2023 · Cancer Research Communications · 88 citations
https://doi.org/10.1158/2767-9764.crc-22-0486
Challenges in the clinical utility of the serum test for HER2 ECD
2012 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 75 citations
https://doi.org/10.1016/j.bbcan.2012.03.012
Mesothelin expression is associated with poor outcomes in breast cancer
2014 · Breast Cancer Research and Treatment · 56 citations
https://doi.org/10.1007/s10549-014-3077-5
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat